These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36503915)

  • 21. Stereoselective Fluorosulfonylation of Vinylboronic Acids for (
    Hong J; Li C; Zhao K; Wang X; Feng R; Chen X; Wei C; Gong X; Zheng F; Zheng C
    Org Lett; 2024 Mar; 26(11):2332-2337. PubMed ID: 38478713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and
    Zhang W; Deng X; Zhang FX; Lin JH; Xiao JC; Liang SH
    Org Lett; 2022 Jul; 24(27):4992-4997. PubMed ID: 35771975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EnT-Mediated N-S Bond Homolysis of a Bifunctional Reagent Leading to Aliphatic Sulfonyl Fluorides.
    Erchinger JE; Hoogesteger R; Laskar R; Dutta S; Hümpel C; Rana D; Daniliuc CG; Glorius F
    J Am Chem Soc; 2023 Feb; 145(4):2364-2374. PubMed ID: 36652725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of Acyl Fluorides from Carboxylic Acids Using NaF-Assisted Deoxofluorination with XtalFluor-E.
    Gonay M; Batisse C; Paquin JF
    J Org Chem; 2020 Aug; 85(15):10253-10260. PubMed ID: 32691597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Mar; 11(2):241-5. PubMed ID: 5654209
    [No Abstract]   [Full Text] [Related]  

  • 26. Photoredox Catalysis-Enabled Sulfination of Alcohols and Bromides.
    Carson Ii WP; Sarver PJ; Goudy NS; MacMillan DWC
    J Am Chem Soc; 2023 Sep; 145(38):20767-20774. PubMed ID: 37721547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A diversity oriented clicking strategy: the stereoselective synthesis of highly-functionalised olefins from 2-substituted-alkynyl-1-sulfonyl fluorides.
    Smedley CJ
    Chem Commun (Camb); 2022 Oct; 58(80):11316-11319. PubMed ID: 36128722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-pot palladium-catalyzed synthesis of sulfonyl fluorides from aryl bromides.
    Davies AT; Curto JM; Bagley SW; Willis MC
    Chem Sci; 2017 Feb; 8(2):1233-1237. PubMed ID: 28451264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract]   [Full Text] [Related]  

  • 30. Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):89-91. PubMed ID: 5763048
    [No Abstract]   [Full Text] [Related]  

  • 31. A rapid access to aliphatic sulfonyl fluorides.
    Xu R; Xu T; Yang M; Cao T; Liao S
    Nat Commun; 2019 Aug; 10(1):3752. PubMed ID: 31434898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
    Baker BR; Erickson EH
    J Med Chem; 1969 Jan; 12(1):112-7. PubMed ID: 5763005
    [No Abstract]   [Full Text] [Related]  

  • 33. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Jan; 12(1):108-11. PubMed ID: 5763004
    [No Abstract]   [Full Text] [Related]  

  • 34. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Jan; 12(1):104-7. PubMed ID: 5763003
    [No Abstract]   [Full Text] [Related]  

  • 35. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
    [No Abstract]   [Full Text] [Related]  

  • 36. Deoxyfluorination of Electron-Deficient Phenols.
    Jelen J; Tavčar G
    Org Lett; 2023 May; 25(20):3649-3653. PubMed ID: 37191994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of sulfonyl-aromatic and sulfonic acid-aromatic interactions in novel sulfonyl/sulfonic acid-embedded reversed phase materials.
    Horak J; Lindner W
    J Chromatogr A; 2008 May; 1191(1-2):141-56. PubMed ID: 18201707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfonic Acid Derivatives in the Production of Stable Co-Amorphous Systems for Solubility Enhancement.
    da Costa NF; Santos IA; Fernandes AI; Pinto JF
    J Pharm Sci; 2022 Dec; 111(12):3327-3339. PubMed ID: 36007560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of acyl fluorides through deoxyfluorination of carboxylic acids.
    Cen M; Yang X; Zhang S; Gan L; Liu L; Chen T
    Org Biomol Chem; 2023 Dec; 21(47):9372-9378. PubMed ID: 37975303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photocatalytic Sulfonyl Fluorination of Alkyl Organoboron Substrates.
    Vincent CA; Chiriac MI; Troian-Gautier L; Tambar UK
    ACS Catal; 2023 Mar; 13(6):3668-3675. PubMed ID: 37124721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.